TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
TELEFLEX INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$129.68−0.75 (-0.58%)
Close on Oct 19, 2026
- Market cap
- $5.66B
- P/E (TTM)
- –
- Dividend yield
- 1.05%
Share price
+$1.55 (+1.21%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
TELEFLEX INC grew revenue 30.7% to $2.25B over the twelve months to Jun 30, 2026. Operating income fell 84.7% to $44.44M, moving the operating margin from 16.9% to 2.0%. Free cash flow was $168.40M, up 789.7% from a year earlier.
Revenue
$2.25B
+30.7% vs. a year earlier
Operating income
$44.44M
-84.7% vs. a year earlier
Free cash flow
$168.40M
+789.7% vs. a year earlier
EPS, diluted
-$23.29
-645.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.66B
- P/E ratio
- –
- Price to sales
- 2.51
- Price to book
- 1.95
- Dividend yield
- 1.05%
- Free cash flow yield
- 2.97%
Fundamentals
- Revenue
- $2.25B
- Net income
- -$1.03B
- EPS, diluted
- -$23.29
- Free cash flow
- $168.40M
- Book value per share
- $66.53
- Diluted shares
- 44M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.25B+30.7% YoY
Gross profit
$1.24B+17.9% YoY
Operating income
$44.44M-84.7% YoY
Net income
-$1.03B-637.5% YoY
EPS, diluted
-$23.29-645.4% YoY
Free cash flow
$168.40M+789.7% YoY
Reported periodTrailing twelve months